<p><strong>Econazole</strong>: compound metabolized by CYP3A4/2C9 oral anticoagulants (warfarin &amp; acenocoumarol).<br />
<br />
<strong>Triamcinolone</strong>: lowering of plasma salicylates levels. Increased risk of Gl bleeding and ulceration with NSAIDs. Antagonised blood glucose-lowering effects of the antidiabetics. Increased risk of Hyperkalemia with amphotericin B, beta-blockers, potassium-depleting diuretics, theophylline. Increased clearance of the triamcinolone with ciclosporin, carbamazepine, phenytoin, barbiturate, rifampicin.</p>